Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Michigan, Ann Arbor, MI 48109, USA.
Am J Respir Crit Care Med. 2013 May 1;187(9):910-4. doi: 10.1164/rccm.201301-0009PP.
In the face of an overwhelmingly large and growing medical literature, providers often turn to clinical practice guidelines to inform the decisions they make with patients. By systematically appraising the evidence and providing transparent recommendations for practice, guidelines have the potential to improve both bedside decision-making and health policy. This potential has not been fully realized because most guidelines lack transparency, are tainted by conflicts of interest, or fail to employ rigorous methods to appraise the evidence. To address the shortcomings of past guidelines, the Institute of Medicine (IOM) published recommendations for trustworthy guidelines, effectively setting the "gold standard" for what constitutes a high-quality guideline. Along with many other groups that develop guidelines, the American Thoracic Society (ATS) is rapidly evolving processes for development and implementation to meet many of the IOM standards. This Pulmonary Perspective describes the rapidly changing landscape of clinical practice guidelines, the role of the ATS in this landscape, and the activities the ATS is engaged in to ensure that the guidelines it produces are of the highest quality with the broadest impact.
面对数量庞大且不断增长的医学文献,医疗服务提供者通常会参考临床实践指南来为患者做出决策。通过系统地评估证据并为实践提供透明的建议,指南有可能改善床边决策和卫生政策。但由于大多数指南缺乏透明度、受到利益冲突的影响,或者未能采用严格的方法来评估证据,因此这一潜力尚未得到充分实现。为了解决过去指南的缺点,美国医学研究所 (IOM) 发布了值得信赖的指南建议,有效地为高质量指南制定了“黄金标准”。与许多其他制定指南的组织一样,美国胸科学会 (ATS) 正在迅速发展开发和实施的流程,以满足 IOM 的许多标准。本《肺部透视》描述了临床实践指南迅速变化的格局、ATS 在这一格局中的作用,以及 ATS 为确保其制定的指南具有最高质量和最广泛的影响而开展的活动。